Bioequivalence in ANDA
Bioequivalence in ANDA means proving that a generic drug delivers the active ingredient into the body at a similar rate and amount as the approved reference medicine. This proof is important in an Abbreviated New Drug Application because the generic medicine must show comparable body performance, not just match the reference drug by name or formula. Active Ingredient Performance Bioequivalence focuses on how the active ingredient behaves after the medicine is taken. The regulator checks whether the generic drug releases and delivers the same active substance in a way that is close to the approved reference product. Rate of Absorption The rate of absorption shows how quickly the active ingredient enters the bloodstream. In bioequivalence testing, this matters because a generic drug should not release the medicine too slowly or too quickly compared with the approved reference drug. Amount Absorbed The amount absorbed shows how much active ingredient becomes available in the b...